search
Back to results

The Expert System VoiceDiab in Children With Diabetes (VoiceDiab)

Primary Purpose

Type 1 Diabetes Mellitus With Hyperglycemia, Type 1 Diabetes Mellitus With Hypoglycaemia

Status
Unknown status
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
VoiceDiab expert system
Sponsored by
Instytut Diabetologii Sp. z o.o.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Type 1 Diabetes Mellitus With Hyperglycemia focused on measuring Bolus calculator, Insulin pump, basal-bolus insulin therapy

Eligibility Criteria

3 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosed type 1 diabetes at least 12 month prior screening visit
  • Current treatment with basal-bolus regime and insulin pump for at least 12 weeks prior screening visit.
  • HbAc < 11%
  • Ability and willingness to adhere to the protocol including self-management and dealing with mobile device.

Exclusion Criteria:

  • Multiply daily injection modality,
  • Treatment with regular insulin,
  • Use of any anti-diabetic agent,

Sites / Locations

  • Ewa PankowskaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

VoiceDiab expert system

manual calculation

Arm Description

the VoiceDiab system using before every main meal; three times per day.

manula insulin calculation before every main meal; three times per day

Outcomes

Primary Outcome Measures

postprandial glucose
postprandial glucose with respect the hyperglycaemia above 180 mg/dl

Secondary Outcome Measures

AUC
he Area Under The Curve (AUC) of postprandial glucose level over 240 minutes,
PPGE- postprandial glucose excursion
Postprandial Glucose Excursions (PPGE), defined as the change in glucose concentration from before the meal to Peak Postprandial Glucose (PPG),
hypoglycemia
Hypoglycaemic episodes over time of observation measeured by CGM
LBGI
Low Blood Glucose Index ( LBGI) - as a one of the glucose variability parameters
Glucose variability parameters
SD total (SDT)- from all days, SD within days (SDw); SD between time points (SDhh:mm); High Blood Glucose Index (HBGI)

Full Information

First Posted
March 26, 2015
Last Updated
May 6, 2015
Sponsor
Instytut Diabetologii Sp. z o.o.
Collaborators
Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, National Center for Research and Development, Poland
search

1. Study Identification

Unique Protocol Identification Number
NCT02403427
Brief Title
The Expert System VoiceDiab in Children With Diabetes
Acronym
VoiceDiab
Official Title
The Voice Decision Support Expert System in Basal-bolus Insulin Therapy of Diabetes Patients.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2015
Overall Recruitment Status
Unknown status
Study Start Date
March 2015 (undefined)
Primary Completion Date
September 2015 (Anticipated)
Study Completion Date
December 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Instytut Diabetologii Sp. z o.o.
Collaborators
Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, National Center for Research and Development, Poland

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study to conduct the preliminary investigation on the efficacy and safety in terms of postprandial glucose value and the rates of hypoglycaemia when expert VoiceDiab system supports patient's decision on prandial insulin programming in insulin pump therapy.
Detailed Description
In children with type 1 diabetes glucose deterioration occurred every day and night leading into low satisfaction with treatment. Unstable glycemic profile resulting in high glycemic variability depends on the adjustment of insulin dosing to the current needs of the organism. The calculation of prandial insulin dosing is a complex process which involves such factors as preprandial blood glucose level, the amount of food taken, the glycemic index of carbohydrates, the insulin/carbohydrate exchange ratio, the active insulin level following the previous bolus. Currently, in patients treated with continuous subcutaneous insulin infusion (CSII) insulin pumps are equipped with bolus calculators which help to calculate prandial insulin dosing and thus contribute to improve post-prandial blood glucose levels. The aim of the study was to determine whether the patient's support expert VoiceDiab system have stabilised diurnal glucose profile in children with type 1 diabetes treated with insulin pumps.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 1 Diabetes Mellitus With Hyperglycemia, Type 1 Diabetes Mellitus With Hypoglycaemia
Keywords
Bolus calculator, Insulin pump, basal-bolus insulin therapy

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
42 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
VoiceDiab expert system
Arm Type
Experimental
Arm Description
the VoiceDiab system using before every main meal; three times per day.
Arm Title
manual calculation
Arm Type
No Intervention
Arm Description
manula insulin calculation before every main meal; three times per day
Intervention Type
Device
Intervention Name(s)
VoiceDiab expert system
Other Intervention Name(s)
patient's decision supporting system
Intervention Description
Decision support system VoiceDiab this is computer-based system constructed for mobile phone devices working on the server. Patients in experimental arm get the mobile phone application for 4 days. Glucose control will be done by two methods SMPG and CGM. Before every study's meal insulin dose with type of bolus will be indicate by VoiceDiab.
Primary Outcome Measure Information:
Title
postprandial glucose
Description
postprandial glucose with respect the hyperglycaemia above 180 mg/dl
Time Frame
96 houres
Secondary Outcome Measure Information:
Title
AUC
Description
he Area Under The Curve (AUC) of postprandial glucose level over 240 minutes,
Time Frame
240 mintues after each study's meal
Title
PPGE- postprandial glucose excursion
Description
Postprandial Glucose Excursions (PPGE), defined as the change in glucose concentration from before the meal to Peak Postprandial Glucose (PPG),
Time Frame
96 houres
Title
hypoglycemia
Description
Hypoglycaemic episodes over time of observation measeured by CGM
Time Frame
96 houres
Title
LBGI
Description
Low Blood Glucose Index ( LBGI) - as a one of the glucose variability parameters
Time Frame
96 houres
Title
Glucose variability parameters
Description
SD total (SDT)- from all days, SD within days (SDw); SD between time points (SDhh:mm); High Blood Glucose Index (HBGI)
Time Frame
96 houres
Other Pre-specified Outcome Measures:
Title
Quality of life
Description
Patients well being when VoiceDiab system is implement
Time Frame
10 days
Title
Patients' acceptances to use VoiceDiab system
Description
based on the study's questioner
Time Frame
10 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosed type 1 diabetes at least 12 month prior screening visit Current treatment with basal-bolus regime and insulin pump for at least 12 weeks prior screening visit. HbAc < 11% Ability and willingness to adhere to the protocol including self-management and dealing with mobile device. Exclusion Criteria: Multiply daily injection modality, Treatment with regular insulin, Use of any anti-diabetic agent,
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ewa Pankowska, PhD
Phone
+48226164474
Email
pankowskae@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Katarzyna Ruszkowska
Phone
+48226164474
Email
ruszkowska.kasia@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Piotr Ladyzynski, PhD
Organizational Affiliation
Institute of Biocybernetics and Biomedicin Engineering in Poland
Official's Role
Study Director
Facility Information:
Facility Name
Ewa Pankowska
City
Warsaw
ZIP/Postal Code
04-736
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katarzyna Ruszkowska
Phone
+48226164474
Email
ruszkowska.kasia@gmail.com
First Name & Middle Initial & Last Name & Degree
Ewa Pankowska, PhD
First Name & Middle Initial & Last Name & Degree
Karolina Mazurczak, MD
First Name & Middle Initial & Last Name & Degree
Piotr Foltynski, PhD

12. IPD Sharing Statement

Citations:
PubMed Identifier
22013887
Citation
Pankowska E, Blazik M, Groele L. Does the fat-protein meal increase postprandial glucose level in type 1 diabetes patients on insulin pump: the conclusion of a randomized study. Diabetes Technol Ther. 2012 Jan;14(1):16-22. doi: 10.1089/dia.2011.0083. Epub 2011 Oct 20.
Results Reference
background
PubMed Identifier
21447273
Citation
Blazik M, Pankowska E. The education of patients in prandial insulin dosing related to the structure of bolus calculators. Pediatr Endocrinol Diabetes Metab. 2010;16(4):301-5.
Results Reference
background
PubMed Identifier
24278682
Citation
Kovatchev BP. Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes. Scientifica (Cairo). 2012;2012:283821. doi: 10.6064/2012/283821. Epub 2012 Oct 17.
Results Reference
background
PubMed Identifier
17109596
Citation
McCall AL, Cox DJ, Crean J, Gloster M, Kovatchev BP. A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus. Diabetes Technol Ther. 2006 Dec;8(6):644-53. doi: 10.1089/dia.2006.8.644.
Results Reference
background
PubMed Identifier
22577884
Citation
Blazik M, Pankowska E. The effect of bolus and food calculator Diabetics on glucose variability in children with type 1 diabetes treated with insulin pump: the results of RCT. Pediatr Diabetes. 2012 Nov;13(7):534-9. doi: 10.1111/j.1399-5448.2012.00876.x. Epub 2012 May 14.
Results Reference
result
PubMed Identifier
20513322
Citation
Pankowska E, Blazik M. Bolus calculator with nutrition database software, a new concept of prandial insulin programming for pump users. J Diabetes Sci Technol. 2010 May 1;4(3):571-6. doi: 10.1177/193229681000400310.
Results Reference
result
PubMed Identifier
19175902
Citation
Pankowska E, Szypowska A, Lipka M, Szpotanska M, Blazik M, Groele L. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes. Pediatr Diabetes. 2009 Aug;10(5):298-303. doi: 10.1111/j.1399-5448.2008.00471.x. Epub 2008 Oct 20.
Results Reference
result
Links:
URL
http://www.ncbi.nlm.nih.gov/pubmed
Description
pubmed

Learn more about this trial

The Expert System VoiceDiab in Children With Diabetes

We'll reach out to this number within 24 hrs